1.5 Teratogens, Exposures & Non-Genetic Risk Factors
Key Takeaways
- A teratogen is an agent that disrupts embryonic or fetal development; risk depends on agent, dose, duration, and gestational timing—not the label alone.
- High-yield teratogens for CGC practice include alcohol, isotretinoin, valproate, warfarin, ionizing radiation, and infections such as CMV, toxoplasmosis, and rubella.
- Maternal PKU and poorly controlled pregestational diabetes are metabolic teratogen contexts that can produce 'genetic-looking' congenital anomalies.
- Non-genetic risk counseling still requires accurate exposure dating, confirmation of exposure when possible, and clear communication of absolute versus relative risk.
- CGC items often trap candidates who treat every anomaly as Mendelian or who ignore that some teratogens remain harmful beyond the classic embryonic window.
Teratogens are environmental agents—drugs, chemicals, infections, physical agents, or maternal metabolic states—that cause structural or functional birth defects. On the CGC exam, Domain 1A expects you to recognize major teratogen classes, match exposure timing to phenotype, and avoid forcing a Mendelian label onto a teratogenic pattern.
Core principles of teratogenicity
Four principles drive counseling:
- Timing — Sensitivity peaks during organogenesis (roughly post-conception weeks 3–8 for many structural defects). Earlier exposure may cause lethality or no effect; later exposure more often affects growth, CNS, or organ function.
- Dose and duration — Higher dose and longer exposure generally raise risk; some agents have steep dose–response curves.
- Genetic susceptibility — Host metabolism and fetal genotype can modify risk; absence of a family history does not rule out teratogenic injury.
- Pattern recognition — Many teratogens produce recognizable phenotypes or patterns rather than a single isolated finding.
Counseling language should distinguish possibility, increased risk, and high likelihood based on evidence quality. Never invent precise percentages when the literature is uncertain; do state when risk is clearly elevated.
Major pharmacologic teratogens
| Agent | Critical period (typical teaching focus) | Classic findings | Counseling notes |
|---|---|---|---|
| Alcohol | Throughout pregnancy; brain vulnerable ongoing | Fetal alcohol spectrum disorders (FASD): growth deficiency, characteristic facies, neurobehavioral disability | No established safe amount or safe trimester; pattern diagnosis is clinical |
| Isotretinoin (systemic retinoid) | Especially early pregnancy / embryogenesis | Craniofacial, conotruncal cardiac, thymic, CNS anomalies (retinoic acid embryopathy) | Extremely high risk with first-trimester exposure; pregnancy prevention programs exist for a reason |
| Valproate | Early pregnancy, neural tube closure window | Neural tube defects, craniofacial features, developmental disability, cardiac anomalies | Risk substantially higher than many other antiseizure medicines; alternatives often considered preconception |
| Warfarin | Especially ~6–12 weeks for embryopathy; later for CNS | Nasal hypoplasia, stippled epiphyses; later exposure linked to brain hemorrhage/CNS injury | Heparin/LMWH often preferred in pregnancy when anticoagulation needed |
| ACE inhibitors / ARBs | More fetopathy in 2nd/3rd trimester | Renal dysplasia, oligohydramnios sequence, skull hypoplasia | Distinguish embryopathy vs fetopathy timing |
| Methotrexate | Embryonic period | Craniofacial, limb, growth, CNS anomalies | Also used in early pregnancy loss management—context matters |
| Thalidomide (historic/high-yield pattern) | Days ~20–36 post-conception | Phocomelia / limb reduction | Classic timing lesson still tested conceptually |
Alcohol
Alcohol is one of the most common preventable teratogens. Counsel that binge and chronic patterns are especially harmful, but no threshold is established as safe. FASD can include smooth philtrum, thin upper lip, short palpebral fissures, microcephaly, and lifelong learning/behavior challenges. Genetic testing may still be indicated to exclude chromosomal or syndromic mimics when the phenotype is ambiguous.
Isotretinoin
Systemic isotretinoin is a prototype high-risk teratogen. Even brief early exposure can produce severe malformations involving cranial neural crest derivatives. Counseling after exposure includes detailed dating, discussion of elevated malformation risk, and coordinated obstetric/genetic evaluation. Topical retinoids are a separate (generally lower) risk discussion—do not conflate them automatically with oral isotretinoin, but do not dismiss all topical concerns without evidence-based nuance.
Valproate and other anticonvulsants
Valproate carries a well-documented increase in neural tube defects and neurodevelopmental impairment. Carbamazepine and some other agents also raise NTD risk, generally less than valproate. Folate supplementation is recommended in antiseizure contexts but does not erase valproate risk. Exam items may contrast "seizure disorder" (maternal disease) with "valproate exposure" (teratogen).
Warfarin
Warfarin embryopathy (nasal hypoplasia, stippled epiphyses) is tied to early exposure; later exposure raises CNS risk via fetal anticoagulation. This timing split is a frequent exam discriminator.
Radiation
Ionizing radiation effects are dose- and timing-dependent. Deterministic effects (malformations, growth restriction, microcephaly, intellectual disability) become clinically concerning above significant fetal dose thresholds, especially in organogenesis and early fetal CNS development. Diagnostic X-rays often involve doses far below those thresholds, but CT, interventional procedures, and therapeutic radiation require case-specific dose reconstruction. Non-ionizing exposures (typical ultrasound, MRI without contraindicated contrast scenarios) are not treated like ionizing teratogens. Counsel against panic over a single dental X-ray while taking high-dose occupational or therapeutic exposures seriously.
Infectious teratogens and perinatal pathogens
| Infection | Key fetal/neonatal pattern | Practical counseling points |
|---|---|---|
| Cytomegalovirus (CMV) | IUGR, microcephaly, periventricular calcifications, sensorineural hearing loss, chorioretinitis | Leading infectious cause of congenital hearing loss; primary infection risk higher than reactivation on average |
| Toxoplasmosis | Intracranial calcifications, hydrocephalus, chorioretinitis | Undercooked meat, cat feces exposure history may matter |
| Rubella | Cataracts, deafness, cardiac defects (e.g., PDA), pigmentary retinopathy | Vaccine-preventable; congenital rubella syndrome is classic |
| Syphilis, parvovirus B19, Zika, varicella, HSV | Varied: hydrops, microcephaly, skin/eye/CNS findings | Recognize that "TORCH" is a teaching shorthand, not a complete list |
Infection counseling requires lab confirmation strategy, gestational timing, and coordinated maternal–fetal medicine care. Genetic counselors help families understand that an infectious etiology can look syndromic and that genetic testing and infectious workup are often complementary, not mutually exclusive.
Maternal metabolic teratogens
Maternal PKU
Uncontrolled maternal phenylketonuria produces a teratogenic embryopathy: microcephaly, intellectual disability, growth restriction, and congenital heart defects. Preconception dietary control of phenylalanine is the prevention strategy. This is a high-yield example of a genetic condition in the mother causing non-Mendelian injury to a genetically unaffected fetus (unless the fetus also inherits PKU risk separately).
Maternal diabetes
Pregestational diabetes with poor peri-conception control increases risk for caudal regression spectrum, neural tube defects, and cardiac malformations. Gestational diabetes arising later has a different risk profile (more growth/metabolic than early structural). Always ask whether diabetes was present before pregnancy and what early glycemic control looked like.
Other non-genetic risk factors
Non-genetic risk is broader than classic teratogens:
- Multifactorial anomalies (isolated NTDs, cleft lip/palate, many CHD) — recurrence risks from empiric data, modified by family history and folate status for NTDs.
- Advanced maternal age — aneuploidy risk (genetic mechanism) vs age-related miscarriage risk; do not confuse with teratogenicity.
- Obesity, smoking, hyperthermia (high fever/hot tubs in early pregnancy) — associated with increased risks for certain defects; counsel with appropriate evidence strength.
- Occupational exposures — solvents, heavy metals, pesticides; often need industrial hygiene detail beyond a yes/no job title.
- Substance use — opioids (neonatal abstinence), cocaine, high-dose vitamin A analogs; distinguish neonatal effects from structural teratogenicity.
Scenario: exposure counseling without overcalling genetics
A client at 8 weeks reports finishing an isotretinoin course two weeks after a positive pregnancy test, with uncertain dating. Best practice: confirm pregnancy dating with early ultrasound, document exact exposure dates and dose, counsel on substantially elevated risk of retinoic acid embryopathy, arrange prompt MFM/genetics follow-up, and discuss reproductive options without coercing a decision. Ordering a hereditary cancer panel because "genetics was consulted" would miss the indication.
Exam traps
- Equating any medication exposure with high teratogenic risk.
- Ignoring timing (warfarin early vs late; ACE inhibitor fetopathy).
- Labeling maternal PKU embryopathy as autosomal recessive disease in the fetus without clarifying mechanism.
- Assuming MMR vaccination in pregnancy is handled identically to wild-type rubella infection risk discussions.
- Forgetting that alcohol and some infections harm the CNS after the embryonic structural window.
- Presenting fabricated precise percentages for poorly quantified exposures.
Mastery of teratogens prepares you for differential building: when the phenotype matches a known exposure pattern, non-genetic etiology rises—but genetic causes are not automatically excluded.
Which exposure–phenotype pairing is most characteristic of warfarin embryopathy from early pregnancy exposure?
A pregnant client with classic PKU asks why preconception diet matters if the fetus does not have PKU. The best counseling explanation is that:
Compared with many other antiseizure medications, first-trimester valproate exposure is especially associated with increased risk of:
A client reports a single dental X-ray with abdominal shielding at 7 weeks gestation. Which counseling approach best reflects teratogen principles?